Abstract: In an era of increasing medical technology and new therapeutic options, classic stroke epidemiology is not thought of as exciting, and its usefulness is questioned by those who think that resources would be better used for new clinical trials, large genetic studies, or translational research. And yet epidemiology is the key to understanding what is really happening in stroke within the population, and it remains the basis for all future research. Without epidemiology, we cannot know who is having strokes or what types of stroke these are, and we cannot monitor the progress of our latest discoveries in stroke prevention and acute treatment. Without epidemiology, we cannot intervene, plan our resources for the future, or direct our treatments to those who most need them. Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based studyThere has been a substantial fall in hypertension-associated intracerebral haemorrhage over the past 25 years, but not in the overall number of cases of intracerebral haemorrhage in older age-groups, in part due to a rise in intracerebral haemorrhage associated with antithrombotic use. These trends, along with the expected increase in prevalence of amyloid angiopathy with the ageing population, suggest that, in contrast to projections based on mortality data below age 75 years, absolute number of cases of intracerebral haemorrhage might increase in future. Full-Text PDF
Publication Year: 2007
Publication Date: 2007-06-01
Language: en
Type: letter
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 14
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot